News
NEW FACTSHEET | The Advanced Therapy Medicinal Products (ATMPs) Labyrinth
The latest addition of the TIF ‘EU Policies Made Simple’ Factsheet Series navigates the complex landscape of Advanced Therapy Medicinal Products (ATMPs) and their ground-breaking potential in the holistic cure of Thalassaemia, Sickle Cell Disease and other Haemoglobinopathies.
Featuring comprehensive information on:
- The Regulation of ATMPs in the EU
- List of gene-based products approved by the EMA/FDA
- Challenges in Patient Access to ATMPs
- Key Recommendations for Improving Patient Access to ATMPs
- ATMPs in Low- and Middle-Income Countries (LMICs): Bridging the Gap, and
- Expanding Access to ATMPs in LMICs: Key Strategies
Download the ATMPs Factsheet HERE.
Download the ATMPs Factsheet HERE.
